Daniel is a senior biopharma leader at GSK, specializing in oncology translational medicine and clinical biomarkers. Holding a PhD from Imperial College London, he leads teams to deliver biomarker strategies for assets throughout clinical development. He has a strong background in both wet lab and in silico science.
He has co-authored key research on the long-term safety and activity of innovative SPEAR T-cell therapies for treating specific cancers like myeloma and sarcoma.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.